Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) Trends and Global Forecasts to 2017
Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implant/artificial organs market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.
The global artificial organs market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Heart bionics accounts for the largest share in this market, primarily due to a large global population with heart diseases. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. The market for certain bionic devices such as exoskeletons, bionic orthopedics, and the bionic eye are skewed in favor of certain regions because of stronger research in these regions as compared to others. In this report, we are also focusing on bionic devices in pipeline, which include wearable artificial kidney, bio-lung, and artificial pancreas.
New and improved technologies, increasing organ failure owing to aging and age-related disorders, increasing accidents and injuries leading to amputations, and rise in number of people awaiting organ transplants are the major drivers slated to propel the growth of this market. However, a few pivotal factors restraining the growth of this market are high cost of devices and uncertain reimbursement scenarios in different regions, limited surgical expertise, and high cost of development. The opportunities in this market for new entrants include improving income levels, and rising awareness in emerging economies.
North America dominates the artificial organs market in 2012, followed by Europe. However, the adoption of novel medical bionics as a therapy in emerging markets is gaining momentum at a fast pace due to a growing population and increasing awareness among patients and players. In addition, increasing healthcare expenditure, growing income levels, rising preference for bionics due to better and efficient recovery as compared to prosthetics, growing surgical procedures in lieu with medical tourism, and lesser competition than mature countries, have amplified the interest of market players in emerging markets.
The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).
Want to explore hidden markets that can drive new revenue in Medical Bionic Implant /Artificial Organs Market?
This research report categorizes the global medical bionic implants market on the basis of products, technologies, and type of fixation. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.
Global Medical Bionics Market, By Products
Vision Bionics
- Bionic Eye
Ear Bionics
- Cochlear Implant
- Bone Anchored Hearing Aid (Baha)
Orthopedic Bionics
- Bionic Limb
- Bionic Hand
- Bionic Leg
- Bionic Knee
- Bionic Feet
- Bionic Finger
- Exoskeleton
- Electrical Bone Growth Stimulators
- Invasive Bone Growth Stimulators
- Non-Invasive Bone Growth Stimulators
Heart Bionics
- Pacemaker
- Implantable Cardiac Pacemaker
- External Pacemaker
- Total Artificial Heart
- Ventricular Assist Device
- Artificial Heart Valves
- Mechanical Heart Valves
- Tissue Heart Valves
Neural /Brain Bionics
- Deep Brain Stimulator
- Vagus Nerve Stimulator
- Spinal Cord Stimulator
Global Medical Bionics Market, By Technology
- Mechanical
- Electronic
Global Medical Bionics Market, By Method of Fixation
- Implantable
- Externally Worn
Medical Bionics Market, By Geography
- North America
- Europe
- Asia-Pacific
- RoW
The term bionics is analogous to the term biomimetics, which involves the study and development of artificial systems that replicate or mimic the functioning of natural biological systems. The science of bionics deals with the application of naturally found biological systems to the study and development of artificially engineered systems. The motive behind developing these artificial systems is to replace and enhance existing natural systems, which may malfunction or fail to function in a desired manner using either mechanical or electronic modalities. The medical bionic implants market is a potentially growing one with a global market of $12.67 million in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.
The global medical bionic implants/artificial organs market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Vision bionics consists of the bionic eye; ear bionics includes cochlear implants and BAHA; orthopedic bionics includes bionic limb, bionic finger, exoskeleton and electrical bone growth stimulators; heart bionics comprises of pacemakers, TAH, ventricular assist devices, and artificial heart valves; and neural/brain bionics consists of deep brain stimulator, vagus nerve stimulator, and spinal cord stimulator. Based on technology, medical bionic implants are divided into two groups - mechanical bionics and electronic bionics. In addition, depending upon the type of fixation, they are classified as externally worn and implantable.
The artificial organs industry is under dramatic transformation globally and will witness significant changes in the coming years, primarily driven by innovation, globalization, and commoditization of products. Amputation, for instance, was considered equivalent to failure to salvage a limb; however, with the presence of advanced powered prosthetics, it is no more considered so. With the advent of bionic technology, amputees have access to limb replacements and enhancement. Orthopedic bionics is more scientifically advanced than prosthetics because it contains specific sensors that can sense and predict user action, based on his/her environment.
Technological innovations in the medical bionic implants industry have been witnessed in the past few years. Newer products with better safety and efficacy contribute to the widespread adoption of medical bionics by physicians worldwide. However, a few pivotal factors restraining the growth of this market are high cost of devices, uncertain reimbursement scenarios in different regions, limited surgical expertise, and high cost of development.
The penetration rate of medical bionics in emerging markets is low. However, established companies and new entrants in the medical bionic implants market should consider the GDP growth rates of these countries, ease of product approval, increasing procedural volumes, and low penetration rates compared to mature markets as factors that will drive growth in these regions.
The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear, Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).
GLOBAL MEDICAL BIONICS IMPLANT /ARTIFICIAL ORGANS MARKET SHARE, BY PRODUCTS, 2017
Source: Annual Reports, SEC Filings, Press Releases, Expert Interviews, MnM Analysis
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 EVOLUTION
3.3 MARKET SEGMENTATION
3.4 BIONICS & PROSTHESES: SIMILARITIES & DIFFERENCES
3.5 MARKET DYNAMICS
3.5.1 DRIVERS
3.5.1.1 TECHNOLOGICAL ADVANCEMENTS
3.5.1.2 INCREASING ORGAN FAILURE OWING TO AGING & AGE-RELATED DISORDERS
3.5.1.3 INCREASING ACCIDENTS & INJURIES LEADING TO AMPUTATIONS.
3.5.1.4 RISE IN NUMBER OF PEOPLE AWAITING ORGAN TRANSPLANTS
3.5.2 RESTRAINTS
3.5.2.1 HIGH COST OF DEVICES AND UNCERTAIN REIMBURSEMENT
SCENARIOS IN DIFFERENT REGIONS
3.5.2.2 LIMITED SURGICAL EXPERTISE
3.5.2.3 HIGH COST OF DEVELOPMENT
3.5.3 OPPORTUNITIES
3.5.3.1 ADVANTAGEOUS IN COMPARISON PROSTHETICS
3.5.3.2 IMPROVING INCOME LEVELS & RISING AWARENESS COULD
PUSH DEMAND IN EMERGING ECONOMIES
3.6 MARKET SHARE ANALYSIS
3.6.1 EAR BIONICS MARKET
3.6.2 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET
3.6.3 HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET
3.6.4 BRAIN/NEURAL BIONICS MARKET
3.7 EMERGING TECHNOLOGIES
3.7.1 BIONICS IMPLANT/ARTIFICIAL ORGANS IN THE PIPELINE
3.7.1.1 ARTIFICIAL PANCREAS
3.7.1.2 BIO-LUNG
3.7.1.3 WEARABLE ARTIFICIAL KIDNEY
4 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 VISION BIONICS
4.2.1 BIONIC EYE
4.3 EAR BIONICS
4.3.1 COCHLEAR IMPLANT
4.3.2 BONE ANCHORED HEARING AID (BAHA)
4.4 ORTHOPEDIC BIONICS
4.4.1 BIONIC LIMB
4.4.1.1 BIONIC HAND
4.4.1.2 BIONIC LEG
4.4.1.2.1 BIONIC KNEE
4.4.1.2.2 BIONIC FEET
4.4.2 BIONIC FINGER
4.4.3 EXOSKELETON
4.4.4 ELECTRICAL BONE GROWTH STIMULATORS
4.4.4.1 INVASIVE BONE GROWTH STIMULATORS
4.4.4.2 NON-INVASIVE BONE GROWTH STIMULATORS
4.5 HEART BIONICS
4.5.1 PACEMAKER
4.5.1.1 IMPLANTABLE CARDIAC PACEMAKER
4.5.1.2 EXTERNAL PACEMAKER
4.5.2 TOTAL ARTIFICIAL HEART
4.5.3 VENTRICULAR ASSIST DEVICE
4.5.4 ARTIFICIAL HEART VALVE
4.5.4.1 MECHANICAL HEART VALVE
4.5.4.2 TISSUE HEART VALVE
4.6 NEURAL/BRAIN BIONICS
4.6.1.1 DEEP BRAIN STIMULATOR
4.6.1.2 VAGUS NERVE STIMULATOR
4.6.1.3 SPINAL CORD STIMULATOR
5 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 ELECTRONIC BIONICS
5.3 MECHANICAL
6 GLOBAL MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY TYPE OF FIXATION
6.1 INTRODUCTION
6.2 EXTERNALLY WORN
6.3 IMPLANTABLE
7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA- PACIFIC
7.5 ROW
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS & ACQUISITIONS
8.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
8.4 NEW PRODUCT LAUNCH
8.5 APPROVALS
8.6 EXPANSION
8.7 OTHER DEVELOPMENTS
9 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, And Developments)*
9.1 ABIOMED, INC.
9.2 BERLIN HEART GMBH
9.3 BIOMET, INC.
9.4 BOSTON SCIENTIFIC CORPORATION
9.5 COCHLEAR, LTD.
9.6 EDWARDS LIFESCIENCES CORPORATION
9.7 EKSO BIONICS
9.8 HEARTWARE INTERNATIONAL, INC.
9.9 IWALK, INC.
9.10 JARVIK HEART, INC.
9.11 LIFENET HEALTH
9.12 MED-EL ELEKTROMEDIZINISCHE GERΔTE G.M.B.H.
9.13 MEDTRONIC, INC.
9.14 NANO RETINA, INC.
9.15 ORTHOFIX INTERNATIONAL N.V.
9.16 OSSUR
9.17 OTTO BOCK HEALTHCARE GMBH.
9.18 SECOND SIGHT MEDICAL PRODUCTS, INC.
9.19 SONOVA HOLDING AG
9.20 ST. JUDE MEDICAL, INC.
9.21 SORIN S.P.A.
9.22 TERUMO CORPORATION
9.23 THORATEC CORPORATION
9.24 TIBION CORPORATION
9.25 TOUCH BIONICS, LTD.
*Details On Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Companies.
LIST OF TABLES
TABLE 1 GLOBAL ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 2 MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 3 VISION BIONICS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 4 GLOBAL EAR BIONICS MARKET, BY PRODUCTS,
2010 2017 ($MILLION)
TABLE 5 EAR BIONICS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 6 COCHLEAR IMPLANT MARKET, BY GEOGRAPHY,
2010 2017 ($MILLION)
TABLE 7 BONE ANCHORED HEARING AID (BAHA) MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 8 GLOBAL ORTHOPEDIC BIONICS IMPLANT (ARTIFICIAL ORGANS) MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 9 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 10 GLOBAL BIONIC LIMB MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 11 BIONIC LIMB MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 12 BIONIC HAND MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 13 GLOBAL BIONIC LEG MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 14 BIONIC LEG MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 15 BIONIC KNEE MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 16 BIONIC FEET MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 17 BIONIC FINGER MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 18 EXOSKELETON MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 19 GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 20 ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 21 INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 22 NON-INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 23 GLOBAL HEART BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 24 HEART BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 25 GLOBAL PACEMAKER MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 26 PACEMAKER MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 27 TOTAL ARTIFICIAL HEART MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 28 VENTRICULAR ASSIST DEVICES MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 29 GLOBAL ARTIFICIAL HEART VALVE MARKET, BY PRODUCT TYPE, 2010 2017 ($MILLION)
TABLE 30 ARTIFICIAL HEART VALVE MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 31 MECHANICAL HEART VALVE MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 32 TISSUE HEART VALVE MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 33 GLOBAL NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 34 NEURAL/BRAIN BIONICS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 35 DEEP BRAIN STIMULATOR MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 36 VAGUS NERVE STIMULATOR MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 37 SPINAL CORD STIMULATOR MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 38 GLOBAL ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY, 2010 2017 ($MILLION)
TABLE 39 GLOBAL MEDICAL BIONIC IMPLANT (ARTIFICIAL ORGANS) MARKET, BY TYPE OF FIXATION, 2010 2017 ($MILLION)
TABLE 40 NORTH AMERICA: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 41 NORTH AMERICA: EAR BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 42 NORTH AMERICA: ORTHOPEDIC BIONIC IMPLANT(ARTIFICIAL ORGANS) MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 43 NORTH AMERICA: BIONIC LIMB MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 44 NORTH AMERICA: BIONIC LEG MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 45 NORTH AMERICA: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 46 NORTH AMERICA: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 47 NORTH AMERICA: ARTIFICIAL HEART VALVE MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 48 NORTH AMERICA: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS,2010 2017 ($MILLION)
TABLE 49 EUROPE: MEDICAL BIONIC IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 50 EUROPE: EAR BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 51 EUROPE: ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 52 EUROPE: BIONIC LIMB MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 53 EUROPE: BIONIC LEG MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 54 EUROPE: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 55 EUROPE: HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 56 EUROPE: ARTIFICAL HEART VALVE MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 57 EUROPE: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 58 ASIA-PACIFIC: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 59 ASIA-PACIFIC: EAR BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 60 ASIA-PACIFIC: ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 61 ASIA-PACIFIC: BIONIC LIMB MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 62 ASIA-PACIFIC: BIONIC LEG MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 63 ASIA-PACIFIC: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 64 ASIA-PACIFIC: HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 65 ASIA-PACIFIC: ARTIFICIAL HEART VALVE MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 66 ASIA-PACIFIC: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 67 ROW: ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 68 ROW: EAR BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 69 ROW: ORTHOPEDIC BIONICS IMPLANT(ARTIFICIAL ORGANS) MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 70 ROW: BIONIC LIMB MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 71 ROW: BIONIC LEG MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 72 ROW: ELECTRICAL BONE GROWTH STIMULATOR MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 73 ROW: HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 74 ROW: ARTIFICAL HEART VALVE MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 75 ROW: NEURAL/BRAIN BIONICS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
TABLE 76 MERGERS & ACQUISITIONS, 2010 2012 TABLE 77 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, 2010 2012
TABLE 78 NEW PRODUCT LAUNCH, 2010 2012
TABLE 79 APPROVALS, 2010 2012
TABLE 80 EXPANSION, 2010 2012
TABLE 81 OTHER DEVELOPMENTS, 2010 2012
TABLE 82 ABIOMED, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 83 ABIOMED, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 84 ABIOMED, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
TABLE 85 BIOMET, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 86 BIOMET, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 87 BIOMET, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
TABLE 88 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 89 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 90 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 91 COCHLEAR, LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 92 COCHLEAR, LTD.: TOTAL REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 93 COCHLEAR, LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
TABLE 94 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE 2009 2011 ($MILLION)
TABLE 95 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 96 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 97 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 98 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 99 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 100 MEDTRONIC, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 - 2012 ($MILLION)
TABLE 101 MEDTRONIC, INC.: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 102 MEDTRONIC, INC.: RESTORATIVE THERAPIES GROUP REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 103 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
TABLE 104 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 105 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 106 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 107 OSSUR HF: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 108 OSSUR HF: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 109 OSSUR HF: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 110 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, 2009 2011 ($MILLION)
TABLE 111 OTTO BOCK HEALTHCARE GMBH. TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 112 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 113 SONOVA HOLDING AG: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 114 SONOVA HOLDING AG: TOTAL REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 115 SONOVA HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
TABLE 116 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 117 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 118 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 119 SORIN S.P.A.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 120 SORIN S.P.A.: TOTAL REVENUE, BY SEGMENTS, 2009 2011 ($MILLION)
TABLE 121 SORIN S.P.A.: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 122 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 2012 ($MILLION)
TABLE 123 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 2012 ($MILLION)
TABLE 124 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 2012 ($MILLION)
TABLE 125 THORATEC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 126 THORATEC CORPORATION: TOTAL REVENUE, BY PRODUCTS LINES, 2009 2011 ($MILLION)
TABLE 127 THORATEC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY PRODUCTS, 2010 2017 ($MILLION)
FIGURE 2 GLOBAL ARTIFICIAL ORGANS MARKET, BY SEGMENTS
FIGURE 3 GLOBAL ARTIFICIAL ORGANS MARKET, BY PRODUCTS
FIGURE 4 ARTIFICIAL ORGANS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 5 EAR BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 6 ORTHOPEDIC BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 7 HEART BIONICS IMPLANT/ARTIFICIAL ORGANS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 8 BRAIN/NEURAL BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 9 CLASSIFICATION OF ORTHOPEDIC BIONICS
FIGURE 10 CLASSIFICATION OF BIONIC LIMBS
FIGURE 11 CLASSIFICATION OF ELECTRICAL BONE GROWTH STIMULATORS
FIGURE 12 GLOBAL MEDICAL BIONIC IMPLANT /ARTIFICIAL ORGANS MARKET, BY TECHNOLOGY
FIGURE 13 GLOBAL ARTIFICIAL ORGANS MARKET, BY TYPE OF FIXATION
FIGURE 14 KEY GROWTH STRATEGIES, 2010 2012
Generating Response ...
Growth opportunities and latent adjacency in Medical Bionic Implant /Artificial Organs Market